TLR4 and metabolic syndrome: Non-haematopoietic TLR4 has been implicated in mediating glucose and insulin intolerance [21,29], and since adipose tissue dysfunction is known to be involved in metabolic syndrome [2,10,13,51], we sought to assess if treatment of EMSCs during differentiation to adipocytes with LPS or palmitate would disrupt normal adipogenesis.